Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease
- PMID: 21785770
- DOI: 10.1039/c1mb05197k
Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease
Abstract
High levels of DNA and RNA released by apoptotic and necrotic cells circulate in the blood of cancer patients. In the present study we determined the applicability of the quantification of nucleic acids and their genetic alterations as minimally invasive tool for breast cancer screening. The relative concentrations of DNA and RNA were determined in preoperative serum of 102 breast cancer patients, 32 patients with benign breast disease and 53 healthy women. The mean follow-up time of the cancer patients was 6.2 years. Loss of heterozygosity (LOH) at four polymorphic markers (D13S159, D13S280, D13S282 at region 13q31-33 and D10S1765 at PTEN region 10q23.31) was analyzed by PCR-based fluorescence microsatellite analyses using cell-free DNA. The serum levels of DNA (p = 0.016) and RNA (p = 0.001) could differentiate between healthy women and cancer patients, but could not discriminate malignant from benign breast lesions. A significant correlation of serum DNA with RNA levels was observed in all groups (p = 0.018). Increased serum DNA levels (but not RNA levels) in cancer patients were associated with a poorer overall (p = 0.021) and disease-free survival (p = 0.025). The occurrence of LOH at all markers significantly correlated with lymph node status (p = 0.026). In addition, the LOH frequency at D13S280 (p = 0.047) and D13S159 (p = 0.046) associated with overall and disease-free survival, respectively. In conclusion, the quantification of cell-free tumour DNA had diagnostic and prognostic values in breast cancer patients, and DNA loss at the region 13q31-33 may be an indication of lymphatic tumour cell spread.
Similar articles
-
Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.Clin Cancer Res. 2012 Oct 15;18(20):5719-30. doi: 10.1158/1078-0432.CCR-12-0142. Epub 2012 Sep 25. Clin Cancer Res. 2012. PMID: 23014523
-
Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.J Surg Res. 1999 May 1;83(1):13-8. doi: 10.1006/jsre.1998.5549. J Surg Res. 1999. PMID: 10210636
-
Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.Ann N Y Acad Sci. 2004 Jun;1022:25-32. doi: 10.1196/annals.1318.005. Ann N Y Acad Sci. 2004. PMID: 15251935
-
Elevated level of cell-free plasma DNA is associated with breast cancer.Arch Gynecol Obstet. 2007 Oct;276(4):327-31. doi: 10.1007/s00404-007-0345-1. Epub 2007 Mar 13. Arch Gynecol Obstet. 2007. PMID: 17431649
-
Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Lung Cancer. 2005 Jul;49(1):1-12. doi: 10.1016/j.lungcan.2004.12.008. Lung Cancer. 2005. PMID: 15949585 Review.
Cited by
-
Cell-free circulating tumor DNA in cancer.Chin J Cancer. 2016 Apr 7;35:36. doi: 10.1186/s40880-016-0092-4. Chin J Cancer. 2016. PMID: 27056366 Free PMC article. Review.
-
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Onco Targets Ther. 2013 Jul 8;6:819-32. doi: 10.2147/OTT.S44668. Print 2013. Onco Targets Ther. 2013. PMID: 23874104 Free PMC article.
-
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001. J Mol Diagn. 2015. PMID: 25908243 Free PMC article. Review.
-
Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection.Oncol Lett. 2018 Sep;16(3):3499-3508. doi: 10.3892/ol.2018.9099. Epub 2018 Jul 6. Oncol Lett. 2018. PMID: 30127954 Free PMC article.
-
Feasibility of Cell-Free DNA Measurement from the Earlobe during Physiological Exercise Testing.Diagnostics (Basel). 2022 Jun 2;12(6):1379. doi: 10.3390/diagnostics12061379. Diagnostics (Basel). 2022. PMID: 35741187 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials